Meso Hair Growth
Androgenic Alopecia and Telogen Effluvium can affect both men and women. Mesotherapy can be used to treat both, with results ranging from good to excellent.
Androgenic Alopecia (AGA) is the commonest form of hair loss affecting both men and women. It affects 50% of men and 20-50% of women by the age of 50.
AGA is caused by progressive, gradual shrinking of normal hair follicles that produce normal (terminal) hairs into miniturized hair follicles that produce fine (vellus) hairs. The terminal to vellus hair ratio, usually 2 to 1 is gradually reduced until it is reversed.
Although AGA is condisered by most doctors to be a cosmetic condition, it can significant psychological and physical effects. Loss of hair allows increased ultraviolet light to reach the scalp, in Australia the largest incidence of malignant melanoma is ocurring in men with balding scalps. Women are particularly prone to suffering the psychological effects of hair loss, as a thick head of hair is highly valued as a sign of feminine beauty in almost every culture.
Most men and women will start hairloss by the age of 40 and many as early as 30.
AGA is distinguised by all other types of hairloss by its gradual onset.
Men present with gradual thinning in the temporal areas and women present with thinning of the hair on the crown.
AGA is inherited, however, it is likely that environmental factors also play a role.
Minoxidil
Minoxidil appears to lengthen the anagen (growth) phase of the hair follicle and also to increase the blood supply.
The Skin and Scalp roller appears to maximize the benefits of minoxidil and results can be seen in 4-6 weeks. Treatments must continue indefinitely as stopping treatment will revert to pretreatment balding.
Finasteride
Finasteride is a 5-alpha-reductase blocker. It is not an antiandrogen and works only with men. It appears to reduce ALA balding and stimulate hair regrowth.
Finasteride must be continued indefinitely, stopping it will cause regression of hair.
In women with ALA, especially those with hyperandrogenism using an estradiol/spironolactone combination can improve their disorder.
Skin & Scalp Pin Roller
The Skin & Scalp Pin Roller uses 96 tiny needles that get to the stratum corneum layer of the epidermis allowing better penetration of the minoxidil.
During the first week of therapy the patient's scalp might be slightly sensitive, however, the patients become accustomed to the treatment very quickly.
Mesotherapy for Hairloss
Alopecia Treatment: is a combination of dutasteride, biotin, pyridoxine, zinc and pantothenic acid.
Dutasteride is more effective than finasteride as it inhibits both I-II isoforms of DHT whereas finasteride only inhibits one.
Biotin, D-Patenol and pyridoxine work together to stimulate hair growth via different mechanisms.
Dutasteride not recommended in women and children.
Androgenic Alopecia (AGA) is the commonest form of hair loss affecting both men and women. It affects 50% of men and 20-50% of women by the age of 50.
AGA is caused by progressive, gradual shrinking of normal hair follicles that produce normal (terminal) hairs into miniturized hair follicles that produce fine (vellus) hairs. The terminal to vellus hair ratio, usually 2 to 1 is gradually reduced until it is reversed.
Although AGA is condisered by most doctors to be a cosmetic condition, it can significant psychological and physical effects. Loss of hair allows increased ultraviolet light to reach the scalp, in Australia the largest incidence of malignant melanoma is ocurring in men with balding scalps. Women are particularly prone to suffering the psychological effects of hair loss, as a thick head of hair is highly valued as a sign of feminine beauty in almost every culture.
Most men and women will start hairloss by the age of 40 and many as early as 30.
AGA is distinguised by all other types of hairloss by its gradual onset.
Men present with gradual thinning in the temporal areas and women present with thinning of the hair on the crown.
AGA is inherited, however, it is likely that environmental factors also play a role.
Minoxidil
Minoxidil appears to lengthen the anagen (growth) phase of the hair follicle and also to increase the blood supply.
The Skin and Scalp roller appears to maximize the benefits of minoxidil and results can be seen in 4-6 weeks. Treatments must continue indefinitely as stopping treatment will revert to pretreatment balding.
Finasteride
Finasteride is a 5-alpha-reductase blocker. It is not an antiandrogen and works only with men. It appears to reduce ALA balding and stimulate hair regrowth.
Finasteride must be continued indefinitely, stopping it will cause regression of hair.
In women with ALA, especially those with hyperandrogenism using an estradiol/spironolactone combination can improve their disorder.
Skin & Scalp Pin Roller
The Skin & Scalp Pin Roller uses 96 tiny needles that get to the stratum corneum layer of the epidermis allowing better penetration of the minoxidil.
During the first week of therapy the patient's scalp might be slightly sensitive, however, the patients become accustomed to the treatment very quickly.
Mesotherapy for Hairloss
Alopecia Treatment: is a combination of dutasteride, biotin, pyridoxine, zinc and pantothenic acid.
Dutasteride is more effective than finasteride as it inhibits both I-II isoforms of DHT whereas finasteride only inhibits one.
Biotin, D-Patenol and pyridoxine work together to stimulate hair growth via different mechanisms.
Dutasteride not recommended in women and children.
